Prolonged exposure to carbachol disrupts the acetylcholine receptor (AChR) clusters of cultured rat myotubes without causing myotube loss. The effect is reversible, and is dependent on temperature. Half-maximal cluster loss is achieved at 3 PM carbachol. Cluster loss is also caused by other agonists of the AChR and is blocked by receptor antagonists. QX314 (a lidocaine derivative), meproadifen, and fluphenazine also completely block cluster loss caused by carbachol. These results are consistent with the idea that cluster loss caused by carbachol and other receptor agonists results from their interaction with the AChR, and the consequent influx of cations into the myotubes. Several experiments suggest that extracellular Na+ and Ca*+ are required, and that at least Na+ must permeate the AChR ion channel for full cluster loss to occur in the presence of carbachol. Depolarization alone is not sufficient to cause cluster loss, however. Ca*+-activated proteases do not play a significant role in carbachol-induced cluster loss.
of carbachol; (2) the cation flux into myotubes following the conformational change; (3) the depolarization following cation flux. I show that the second possibility, cation flux through the receptor channel, accounts for the destabilizing effect of carbachol on AChR clusters. These results are consistent with the idea that the stability of the AChR clusters of cultured rat myotubes is dependent on the intracellular ionic milieu.
Materials
and Methods Methods for preparing myotube cultures, for staining them with tetramethylrhodamine-cu-bungarotoxin (R-BT; Ravdin and Axelrod, 1977) , and for analyzing AChR clusters have been presented in detail elsewhere (Bloch, 1979 (Bloch, , 1983 . In brief, rat myotube cultures, grown on glass coverslips, are washed with Dulbecco-Vogt modified Eagle's medium (DMEM) buffered with HEPES, then covered with DME&I containing 5% fetal calf (Gibco. Grand Island. NY) or cadet calf serum (Biocell Laboratories, barson, CA), and incibateh with or without the addition of drugs for 6 hr at 37°C in an atmosphere of 94% air, 6% CO,. Cultures are washed extensivelv with HEPES-buffered DMEM. stained with R-BT. fixed, and observed-under fluorescence optics to hetermine the per: centage of the total myotubes displaying large, flat AChR clusters on their ventral surfaces.
A cluster is defined as a discrete region of the myotube surface, -40 pm2 in area, that stains brightly with R-BT, is neither linear nor an artifact of the overlapping of two or more cells, and is not located on a cellular process isolated from the muscle cell or detached from the tissue culture substrate (Bloch. 1979) . Usuallv 50 mvotubes ner culture were analyzed, and eacd expehmental value Is the average ok duplicate or triplicate determinations. Values generally vary by f 10% myotubes with clusters (e.g., Tables 3 and 5, below) .
Influx experiments with 22Na+ were performed as described by Bloch (1979) and Stallcup and Cohn (1976) , except that the temperature was 35-37"C, and incubations were performed for 15 min. Longer exposure to carbachol before assay also resulted in increased 22Na+ influx, but was not as quantitatively reproducible and so was not pursued further.
The sources of most materials have been reported earlier (Bloch, 1979) . Nicotinic and muscarinic cholinergic drugs and other neurotransmitter receptor ligands were purchased from Sigma Chemical Company (St. Louis, MO) or were gifts from Dr. J. Patrick (Neurobiology Laboratory, The Salk Institute, La Jolla, CA). Leupeptin, aprotinin, pepstatin, and L-seryl-L-leucine were purchased from Sigma. The protease inhibitor, Ep475, was kindly provided by Dr. L. Waxman (Department of Physiology, Harvard Medical School). Fluphenazine and meproadifen were the gifts of Drs. B. Krueger and E. Albuquerque (Departments of Physiology, and Pharmacology, respectively, University of Maryland School of Medicine).
Results
Cluster loss caused by carbachol In cultures of rat myotubes, 70-90% of the myotubes normally display large clusters of AChR, which can be visualized after staining with R-BT. Upon exposure to 10m4 M carbachol, the fraction of myotubes displaying clusters decreases to ~30% (Bloch, 1979) . This loss of clusters occurs as a linear function of time up to 6 hr ( Fig. 1) . As the effects of carbachol on AChR Bloch Vol. 6, No. 3, Mar. 1986 At the times indicated, the cultures were removed from the incubator, washed extensively with buffered medium, stained with R-BT, and observed under fluorescence. Myotubes with AChR clusters were quantitated as described in Methods. The results show that cluster loss is induced by carbachol, but not by d-tubocurarine, and that it proceeds as a linear function of time of treatment.
clusters are apparent at 6 hr, this time was routinely used in the experiments presented here. Data in Figure 1 further suggest that the failure to detect AChR clusters was not due to incomplete removal of carbachol before staining with R-BT. For example, similar amounts of carbachol should remain after washing cells treated for 2 and 6 hr, but the percentage of myotubes with clusters at 6 hr is one-third that seen after 2 hr oftreatment. Also, d-tubocurarine at 1 O-4 M causes no loss of clusters, despite the fact that it has a higher affinity for AChR than does carbachol. Thus, residual carbachol does not compete with R-BT and prevent the visualization of AChR clusters. In the experiments presented below, I show that cluster loss is not the result of irreversible loss or damage sustained by myotubes, but is, instead, caused by carbachol interacting with the nicotinic AChR and inducing the influx of cations, primarily Na+, into the myotubes.
I first addressed the possibility that carbachol caused the loss of entire myotubes displaying clusters. A total of 194 cells in four myotube cultures were identified and photographed. Two cultures were incubated under control conditions, and two were incubated similarly but in the presence of 1 O-" M carbachol. The cultures were then stained with R-BT, and the identified cells were observed and rephotographed. The results (Table 1) show that most of the control cells were present after 6 hr of incubation and that most of these displayed AChR clusters. Most of the carbachol-treated cells were also recovered after 6 hr, but only 4% of these had clusters. Examples are presented in Figure 2 . The results indicate that carbachol causes AChR clusters to be lost without causing significant loss of muscle cells.
Carbachol-treated cells underwent some change in shape, however (Fig. 2, A and B, white arrows). After treatment with 1O-4 M carbachol, the cusps of the myotubes appeared broader and the myotube sections connecting the cusps appeared narrower. Although these shape changes accompany the loss of clusters, more extensive changes in myotube shape are induced by colchicine, without extensive cluster loss (Bloch, 1979 (Bloch, , 1983 , suggesting that alteration of myotube shape is itself not sufficient to cause loss of AChR clusters. Vacuolization, observed in some carbachol-treated cells (Fig. 2B , black arrowhead) did not always accompany loss of AChR clusters, as less than 15% of the muscle cells became vacuolated during exposure to carbachol.
I next determined if the effect of carbachol on AChR clusters was reversible. After exposure to 1O-4 M carbachol for 6 hr, cultures were washed extensively in fresh medium and incu- Myotube cultures on glass coverslips were mounted into a special incubation chamber . Selected fields were photographed at low magnification, and their grid positions were noted. These photographs subsequently gave the number of myotubes present in the selected fields at the beginning of the experiment (t = 0). The cultures were then placed into a solution consisting of DMEM plus 5% cadet calf serum. Half of the chambers also contained 10m4 M carbachol. Cultures were incubated for 6 hr at 37"C, washed free of the incubation medium and stained with R-BT. After staining, the cultures were fixed in 2% paraformaldehyde.
The same grid positions were relocated and photographed. These photographs subsequently gave the number of myotubes present in the same fields at the termination of the experiment (t = 6 hr). The myotubes in these selected fields were then observed with fluorescence optics under high magnification to determine whether AChR clusters were present, as outlined in Methods. These data are contained in the row labeled "Myotubes with clusters," t = 6 hr.
bated for an additional 18 hr. Upon staining with R-BT, most of the myotubes present at the end of the experiment contained AChR clusters (see Table 2 ). Similar results were obtained when myotube cultures were stained with R-BT after the 6 hr exposure to carbachol but before the 18 hr recovery period (see Table 2 ). Thus, all the clusters seen after the 18 hr recovery contained AChRs that were present before recovery began. This suggests that the reappearance of AChR clusters was not due to the formation of new myotubes during the recovery period. The possibility that massive loss of muscle cells occurred during the recovery period was ruled out by measuring the number of IZ51-BT binding sites in the cultures immediately after carbachol treatment and again after recovery. In two experiments, lZ51-BT binding was 34 and 4 1% greater after recovery than immediately after the 6 hr treatment with carbachol. Together with the data in Table 2 , this finding rules out the possibility that the cells left after recovery were only those cells that resisted the effects of carbachol. I conclude that the carbachol-induced loss of AChR clusters is reversible.
I observed the disruptive effects of carbachol on AChR clusters in all the experiments (total of 59) I performed. In 12 (20%) of these experiments, however, the effect of carbachol treatment was quantitatively diminished, resulting in 40-5 5% of myotubes with clusters after 6 hr, rather than the usual 20-30%. This variability may depend on the state of development of the cultures, but I have not found a consistent effect either of culture age or of initial plating density. Unless otherwise stated, the results reported here represent only those experiments in which carbachol treatment resulted in ~40% of myotubes with clusters. The experiments that have been omitted always gave qualitatively similar results. Quantitatively, however, drugs that block AChR cluster loss in the presence of carbachol are generally more potent when carbachol-induced cluster loss is diminished.
Recently, considerable attention has been given to the AChR clusters that form on the dorsal or upper myotube surface, distant from the tissue culture substrate. Dorsal clusters, too, are destabilized by carbachol: In two experiments, the percent of myotubes with dorsal clusters decreased by 40 and 69%, as compared to controls. The effects of carbachol on the ventral clusters were quantitatively similar. In my cultures, dorsal clusters are generally infrequent and more variable than are ventral clusters (from 23 to 5 1% myotubes with dorsal clusters, in six Figure 2 . The effect of carbachol on cell number and AChR clusters in identified cells. Cultures were processed as described in the legend to Table   1 . At the beginning of the experiment, phase micrographs were taken of control cultures (not shown) and of cultures to which carbachol had just been added (A). Cultures were then replaced at 37°C for 6 hr. After this incubation, cultures were labeled with R-BT and fixed with parafotmaldehyde. The same fields were relocated and photographed again (& for carbachol-treated sample). The magnification was then increased, and individual control (C, D) and carbachol-treated (E, F) cells were examined and photographed under phase (C, E) and fluorescence (D, F) illumination to determine if AChR clusters were present. Panels E and F show the cell marked with the white arrow in B. This figure shows that most cells are recovered after treatment with carbachol, but that, unlike control cells, they do not contain AChR clusters. It also illustrates some of the shape changes (compare cell indicated by the white uvows in A and B) and occasional vacuolization (e.g., the cell indicated by the black arrowhead in B) that treatment with carbachol may induce. The clearer view of the nuclei in C', compared to E, is due to the fact that the cell in C is spread more, and not to any significant change in the appearance of the myoplasm after carbachol treatment. The bar in F represents 20 pm for panels C-F, and 80 rrn for panels A and B. Myotube cultures were incubated with and without carbachol (10-l M) for 6 hr at 37°C. They were then washed extensively. Duplicate samples were withdrawn, stained with R-BT, fixed in cold ethanol, and stored until the termination of the experiment. Data for these samples are given in the columns labeled "After initial incubation."
For the samples in column A, remaining cultures were replaced in control medium and incubated at 37°C for an additional 16-18 hr. Thereafter, they were stained with R-BT and fixed. For the samples in column B, remaining cultures were first stained with R-BT and then replaced in control medium. After the additional incubation, they were fixed without restaining. All samples were mounted in glycerol, and myotubes with clusters were quantitated as described in Methods. a Initial incubation. b Not determined.
control samples) and are harder to visualize. They were, therefore, only examined occasionally.
Pharmacology
Further experiments, summarized in Table 3 , showed that the effects of carbachol are the result of its interaction with AChR.
(1) All agonists of the AChR, including neostigmine (Bloch and Stallcup, 1979) , cause extensive cluster loss. (2) Partial agonists, such as decamethonium (Adams and Sakmann, 1978) , cause less extensive cluster loss. (3) Antagonists, such as d-tubocurarine and benzoquinonium, alone have no effect on AChR clusters, but they reduce or prevent the effect of carbachol. (4) A local anesthetic, QX3 14, which blocks the AChR ion channel in its open conformation (Neher and Steinbach, 1978) , blocks the carbachol-induced loss of AChR clusters. (5) Meproadifen and phenothiazines, which accelerate AChR desensitization (Carp et al., 1983; Krodel et al., 1979; Maleque et al., 1983) , also prevent carbachol-induced cluster loss. Thus, reagents that cause AChR channel opening cause cluster loss, and reagents that block channel opening or reduce the channel open time prevent cluster loss.
The effects of different concentrations of several of these drugs are presented in Figure 3 . Carbachol causes half-maximal cluster loss at a concentration of 3 PM (Fig. 3A ). Decamethonium shows a biphasic effect on AChR clusters: At 1O-5 M, it causes some cluster loss, but at lo-" M it causes no cluster loss (Fig. 3B ).
These dual effects of decamethonium are probably due to the fact (Adams and Sakmann, 1978) loss at the same concentrations at which trifluperazine, a closely related phenothiazine, promotes receptor desensitization (Carp et al., 1983; Maleque et al., 1983) . Qualitatively, the results shown in Figure 3 and Table 3 are consistent with the idea that the loss of AChR clusters is a nicotinic cholinergic effect.
Ionic dependence
Three distinct mechanisms could account for the effect of carbachol on AChR clusters. (1) Carbachol may induce a confor- Myotube cultures were incubated for 6 hr at 37°C with the indicated drug, alone or together with 10e4 M carbachol. Cultures were washed extensively to remove the ligands, stained with R-BT, fixed in cold ethanol, and mounted in glycerol.
Myotubes with clusters were quantitated as described in Methods. 0 Mean +-SD, followed by the number of determinations, in parentheses. h Not determined. ( DMPP, 1,l -dimethyl-4-phenylpiperazinium iodide. d Cultures were preincubated with 5 &ml R-BT for 20 min. Cultures were then washed extensively and incubated for 6 hr, as for the other samples. c Value obtained when carbachol alone gave only 49% myotubes with clusters. mational change in AChR that is sufficient to induce cluster loss. (2) Ion flux through the receptor ion channel must occur. (3) Depolarization, which is long-lasting in carbachol-treated rat myotubes (Ritchie and Fambrough, 1975a) , is sufficient to cause cluster loss.
The results reported in Table 2 make the first possibility unlikely. For example, QX3 14 does not appear to alter the rates of channel opening and closing or of receptor desensitization (Neher and Steinbach, 1978) . As QX3 14 inhibits the effects of carbachol, the conformational changes associated with these receptor functions are apparently not sufficient to cause cluster loss. I therefore concentrated on the latter two possibilities.
To test the third possibility, I incubated myotubes in medium containing 145 mM K+. When the counterion was chloride, cluster loss was extensive (giving < 10% myotubes with clusters, in two experiments) and was accompanied by swelling of the myotubes and other morphological changes. (Additional changes in the appearance of myotubes treated with high concentrations of KC1 include the presence of more clearly defined nuclei, with darkened nuclear envelope, lighter nucleoplasm, and condensed Myotubes with clusters were quantitated as described in Methods. A, Carbachol shows a half-maximal effect on cluster stability at 2.5 PM. B, Decamethonium shows a biphasic effect. C, Benzoquinonium (x) and d-tubocurarine (0) alone have no effect on AChR clusters, but d-tubocurarine in the presence of 1 O-4 M carbachol(0) inhibits cluster loss with a half-maximal effect at 7 FM. D, Trifluperazine alone (0) has no effect on cluster stability, but in the presence of 10m4 M carbachol (0) it inhibits cluster loss with a half-maximal effect occurring between 5 and 10 FM.
nucleoli. These changes are not observed in myotubes treated with carbachol or with K-methane sulfonate.) When the counterions were 4 mM Cl-and 14 1 mM methane sulfonate, however, I found no loss of AChR clusters (78 + 5% myotubes with clusters, n = 3), and no swelling. As myotubes are depolarized to -1 t 0.7 mV (mean + SD, n = 3 cells in a single culture, measured with an intracellular microelectrode) by high concentrations of K+-methane sulfonate, depolarization is not sufficient to cause cluster loss. I ruled out the possibility that Cl-was important for cluster loss in two separate experiments. In medium containing 145 mM Na+, supplemented with 30 mM KC1 (insufficient to cause cluster loss by itself), and containing -140 mM Cl-, carbachol treatment was unable to disrupt AChR clusters (67 f 10% myotubes with clusters, n = 3). Under these conditions, elevated K+ may reduce Na+ movement through the AChR ion channel by competing for access to the channel, and also by reducing the driving force for Na+ influx. In the second experiment, carbachol treatment in the presence of 4 mM KC1 and 14 1 mM Na-methane sulfonate resulted in normal cluster loss (43% myotubes with clusters, compared to 40% in medium containing 145 mM Cl-, in a single experiment). Both these experiments suggest that Clis not essential for cluster loss to occur in the presence of carbachol. (Bloch, 1983) containing radioactive Na+ at 35-37°C in the presence of the indicated concentration of carbachol. After 15 min, cultures were rapidly washed free of unbound 22Na+, and the radioactivity taken up per culture was determined. More details are given in Stallcup and Cohn (1976) . Each point is the mean f SD ofthree samples. The results show that over a 15 min incubation period, carbachol stimulates **Na+ uptake by myotube cultures with a half-maximal concentration of approximately 3 ~h4.
The most likely explanation of the effects of carbachol on AChR clusters is that carbachol treatment causes an influx of cations into the myotube, altering the intracellular milieu and thereby destabilizing clusters. As Na+ is the predominant cation in culture medium that can permeate the AChR channel (Huang et al., 1978; Ritchie and Fambrough, 1975b; Takeuchi and Takeuchi, 1960 ) I attempted to correlate Na+ entry into myotubes with carbachol-induced cluster loss. I first determined the dependence of 22Na+ influx on carbachol concentration, assaying after 15 min at 37°C as a compromise between conditions used for kinetic measurements (5-l 0 set) and those used to observe cluster loss (2-6 hr). As shown in Figure 4 , the concentration of carbachol that gave a half-maximal **Na+ influx was 3 MM (Fig. 3A) . The similar half-maximal concentrations for cluster loss and **Na+ influx suggest that the two processes are related. Second, I found that lowering the extracellular Na+ concentration reduces the effect of carbachol. The data in Figure 5B show that partial protection against cluster loss was obtained when the extracellular Na+ concentration was reduced to 60 mM. At [Na'],, less than 30 mM, myotubes contracted and were lost from cultures, perhaps because Ca*+ influx through the AChR ionophore contributed more to net cation influx (e.g., Huang et al., 1978; Stallcup, 1979) . These results are consistent with the idea that Na+ flux into myotubes is at least in part responsible for AChR cluster loss induced by carbachol.
Two additional observations support this idea.
(1) Veratridine, an alkaloid that specifically opens voltage-gated Na+ channels in excitable cells (Catterall and Nirenberg, 1973; Stallcup and Cohn, 1976 ) causes extensive AChR cluster loss. At 2.5 x 1 Om4 M, veratridine left only 2 1 + 14% (n = 3) of myotubes with clusters. At the same time, however, it causes severe changes in cell shape. (2) Gramicidin S, an ionophore that forms specific channels for Na+ and K+ in cell membranes (Jain, 1972) , at 10 &ml also causes significant AChR cluster loss (leaving 35 and 14% myotubes with clusters in two experiments). At higher concentrations, however, this reagent causes massive contraction and cell loss. Despite the difficulties involved in their use, Bloch Vol. 6, No. 3, Mar. 1986 Ca*+(mM) Figure   5 . Effect of altering the extracellular salt concentrations on cluster loss induced by carbachol. Myotube cultures were placed into tissue culture medium containing the concentration of Ca2+ indicated on the abscissa, and either 150 mM NaCl (closedcircles) or 60 mM NaCl (open squares). Isotonicity was maintained by the addition of sucrose. Cultures were then incubated either in the absence (A) or presence (B) of 10m4 M carbachol for 6 hr at 37°C. After staining with R-BT and fixation, AChR clusters were quantitated as described in Methods. The raw data are presented in A and B. Panel C shows the results expressed as the percent control values, which were obtained by dividing the values found in the presence ofcarbachol (B) by the values found in its absence (A) under otherwise identical conditions. In agreement with other reports (Bloch, 1983; Bursztajn et al., 1984) , the results show that lowering extracellular Ca2+ causes AChR cluster loss (A, solid line) and that this requires the presence of high extracellular Na+ (A, dotted line). In the presence of carbachol (B and, after normalization, C), lowering extracellular Na+ protects most of the AChR clusters from disruption (dotted lines). This protection is extended to more myotubes with clusters when extracellular Ca*+ is lowered (solid lines). both these reagents increase the permeability to Na+, and both cause the loss of AChR clusters. Any means of increasing Na+ influx may therefore disrupt AChR clusters. As lowering extracellular Na+ only partially protects against cluster loss, Na+ is probably not the only cation involved, however. As reported elsewhere (Bloch, 1983; Bursztajn et al., 1984) lowering [Ca2+10 to concentrations below 0.4 mM causes cluster loss, and this loss is prevented by simultaneously reducing [Na'],, (Fig. 54) . The effect of very low concentrations of extracellular CaZ+ on carbachol-induced AChR cluster loss could therefore not be determined. At [Ca2+lo between 0.4 and 2.0 mM, however, I observed greater protection against the effects of carbachol. In medium containing 60 mM Na+, decreased [Ca2+10 prevented an additional lo-20% of cluster loss (Fig. 5B, dotted line) . After normalization for the effects of the changes in salt concentration on controls, however, lower [Ca2+10 at 60 mM NaCl only gave additional protection against carbachol-induced cluster loss in the upper range of concentrations assayed (Fig. SC, dotted Myotubes were preincubated with protease inhibitor at the desired concentration for the period of time noted. Carbachol was then added to half of the cultures to a final concentration of 1O-d M. After 6 hr of incubation at 37°C cultures were washed, stained with R-BT, fixed, and observed for AChR clusters. Q The units are: TIU, trypsin inhibitory units, as defined by the manufacturer (Sigma). b Not determined. c In experiment 4, carbachol had a less marked effect than in most of the other experiments reported here. Usually when this occurred, inhibitors of cluster loss were more potent. In this case, however, protease inhibitors were unable to protect a significant number of receptor clusters from the disruptive effects of carbachol, despite the fact that they were used at high concentrations. d This difference is within the standard range of variability for such measurements (see Methods).
clusters from disruption (Fig. 5B, solid line) . This effect is even more apparent when normalized to account for changes in the control values at the same salt concentrations (Fig. SC, solid  line) . These experiments suggest that [Ca2+lo may also be involved in the loss of AChR clusters caused by carbachol.
Protease inhibitors Salpeter and her colleagues (Leonard and Salpeter, 1979; Salpeter et al., 1982b) have reported that alterations in postsynaptic morphology of muscle caused by carbachol may be due to Ca2+ influx into the end-plate region and subsequent activation of Ca2+-dependent neutral proteases. Carbachol-induced damage is reduced in muscles incubated in medium lacking Ca2+ or in medium containing the protease inhibitor, leupeptin (Salpeter et al., 1982b) . It seemed reasonable to postulate that AChR clusters in cultured myotubes might be disrupted by a similar mechanism. I therefore treated myotube cultures with leupeptin or with an inhibitor specific for Ca2+-activated thiol proteases, Ep475 (Rodemann et al., 1982) , for up to 16 hr, to allow the reagents to gain access to the cytoplasmic compartment, then exposed them to carbachol for 6 hr in the continued presence of these reagents. The results of these experiments (Table 4) show that neither leupeptin nor Ep475 protects myotubes from carbachol-induced AChR cluster loss. Aprotinin and pepstatin (Table 4) , and L-seryl+leucine (not shown), also failed to inhibit Myotube cultures were incubated in the presence of the drugs listed, with or without carbachol (lo-' M), for 6 hr at 37°C. Cultures were then washed, stained with R-BT, fixed, and analyzed for myotubes with AChR clusters. a Unless otherwise indicated, the values in this column are from Bloch (1979 Bloch ( , 1983 . b When appropriate, results are expressed as means ? SD, followed by the number of determinations (in parentheses). 5 Values from Table 2 . d Values not previously reported. c The medium already contained 2 mM M&I,, so the final concentration was 6 mw 'Samples were fixed for S min at 22°C in 2% (wt/vol) paraformaldehyde in buffered saline before being placed into incubation with or without carbachol. I: Incubations were conducted as for the other samples described, but the temperature was kept at 22°C.
cluster loss in the presence of carbachol. These results suggest that carbachol does not cause cluster loss in cultured myotubes solely by activating Ca2+-dependent neutral proteases.
Other drugs
To define further the possible changes in myotubes caused by carbachol, I examined the effects of several other treatments and drugs (Table 5 ). Only prefixation with paraformaldehyde, incubation at room temperature, or incubation in the presence of concanavalin A protected against cluster loss, perhaps by reducing the mobility of AChR in the myotube membrane. Ba2+, but no other divalent cation, gave partial protection. Colchicine, which partially protects against AChR cluster loss in Caz+-free medium (Bloch, 1983) , had no effect. Ouabain, which should potentiate the increase in intracellular Na+ initiated by carbachol, increased both cluster loss and loss of myotubes due to contraction. Other drugs that had no effect on the loss of clusters induced by carbachol include 3',5'-CAMP, 3',5'-cGMP, and their dibutyryl derivatives, all assayed at 1 mM in the presence or absence of theophylline (1 mM), theophylline alone (1 mM), caffeine (2 mM), dimethylsulfoxide (lo/o), and ethanol (1%). Other neurotransmitter agonists and antagonists also failed to alter AChR cluster stability. Reagents tested include histamine, glytine, glutamate, y-aminobutyric acid, epinephrine, norepinephrine, and serotonin, all at 10d4 M.
Discussion
Nicotinic cholinergic eflect Exposure of cultured rat myotubes to carbachol causes the disappearance of AChR clusters from the myotube membrane. The mechanism of this disappearance, or loss, is still not known.
Several possibilities are highly unlikely, however. (1) Cluster loss is not the result of massive loss of myotubes or of irreversible damage to the myotubes. (2) It is probably not the result of the changes in cell shape accompanying exposure to carbachol. More extensive changes in shape are induced by exposure to colchicine, for example, without significant cluster loss. Furthermore, myotube-substrate contacts, at which clusters are often found (e.g., Bloch and Geiger, 1980; Land et al., 1977) , are not significantly altered during carbachol treatment (R. J. Bloch, unpublished observations), and the organization of membrane domains in this region of the cell is not lost as clusters are disrupted during exposure to carbachol (D. W. Pumplin and R. J. Bloch, unpublished observations). These observations suggest that carbachol does not grossly deform the regions of the myotubes at which clusters are normally found. (3) Cluster loss is probably not the result of the shedding of clusters from the cell. In cases where this has been observed (e.g., Bloch, 1984 , and unpublished observations), clusters are shed onto the adjacent tissue culture substrate. No such shedding was observed in these experiments. (4) Disappearance is probably not the result of carbachol remaining bound or trapped by clustered receptors. Instead, the results presented here show that the loss of AChR clusters seen in rat myotube cultures treated with carbachol is a pharmacological effect mediated by ion flux through the AChR channels.
The pharmacology of cluster loss is nicotinic cholinergic. Cluster loss is caused by a variety of nicotinic agonists and blocked by classical nicotinic antagonists, including BT. It is also inhibited by the local anesthetic, QX3 14, and by meproadifen. As argued in Results, the effects of these drugs are not consistent with the idea that carbachol causes the loss of AChR clusters simply because it induces a conformational change in the receptors that renders them less able to cluster. Instead, some effect that follows agonist-induced conformational changes must be responsible for cluster loss in the presence of carbachol. This effect is not simply membrane depolarization, however, as K+ at high concentrations (with methane sulfonate as the counterion) does not cause the loss of AChR clusters. Thus, cluster loss probably results from the flux of particular ions through the AChR channels opened by carbachol.
Several results suggest that, of the cations that permeate the AChR channel, Na+ is the most important. (1) Carbachol stimulates *2Na+ flux and cluster loss with the same half-maximal concentration. (2) Two other reagents that stimulate Na+ influx, veratridine and gramicidin, also cause AChR cluster loss. (3) Reducing extracellular Na+ concentrations prevents much cluster loss. This interpretation is also consistent with the observed effect of electrical activity on AChR clusters. For example, Axelrod et al. (1978) showed that repeated electrical stimulation of myotube cultures caused the AChR clusters to be lost. Such stimulation would tend to increase intracellular Na+. Several investigators have further reported that TTX, which should block spontaneous opening of the voltage-activated Na+ channel and thereby prevent an increase in intracellular Na+ levels due to such openings, promotes the formation of AChR clusters (e.g., Harris, 198 1; Prives et al., 1976; Ziskind-Conhaim and Bennett, 1982) . Treatments that increase [Na+li are therefore likely to disrupt AChR clusters, and treatments that block such increases are likely to promote cluster formation.
One difficulty with this interpretation is that the concentrations of nicotinic drugs needed to affect AChR clusters do not consistently agree with published values of their affinities for AChR on the surface of mammalian cells (e.g., Patrick et al., 1977; Sine and Taylor, 1979, 198 1) . These differences are probably the consequence of studying long-term effects, involving processes other than AChR channel opening (e.g., a gradual reduction in the driving force for Na+ influx or a change in the activity of the Na+-K+ pump). A similar half-maximal concen-tration for carbachol has been reported by Lindstrom et al. (1980) who studied 22Na+ flux into small vesicles, stimulated by carbachol interacting with AChR, at times much later than those required to observe true initial velocities.
A second possible difficulty with this interpretation is the observation by Ziskind and Dennis (1978) and others (Morris et al., 1983; Trautmann, 1982 ) that d-tubocurarine can act as a nicotinic agonist in embryonic rat muscle. Ziskind and Dennis (1978) report, however, that bath application of d-tubocurarine to embryonic muscle depolarizes embryonic muscle fibers to -50 mV. In contrast, carbachol causes long-lasting depolarization of cultured rat myotubes to 0 to -10 mV (Ritchie and Fambrough, 1975a) . Thus, d-tubocurarine probably fails to disrupt clusters because it is not a sufficiently potent receptor agonist.
Role of Ca2+
Although Na+ flux through the AChR channel appears to be important for cluster loss to occur in the presence of carbachol, it may not be sufficient. Some protection against cluster loss is afforded by reducing extracellular Ca*+ concentrations two-to fourfold, and nearly complete protection is afforded by reducing both Na+ and Ca2+. In addition, Ba2+ partially blocks cluster loss (Table 5 ) without interfering with carbachol-stimulated 22Na+ influx (Bloch, unpublished observations) . BaZ+ is more likely to act at divalent than at monovalent cation binding sites. I tentatively conclude, therefore, that both Na+ and Ca2+ promote AChR cluster loss in the presence of carbachol.
How does the movement of Na+ through the AChR ion channel, in the presence of extracellular Ca2+, destabilize AChR clusters? Answering this question requires that we know where Ca2+ acts. In principle, its site of action could be intracellular, extracellular, or within the plasma membrane. If Ca2+ acts intracellularly, its intracellular concentrations may be elevated via a Na+-for-Ca*+ exchange mechanism (e.g., Blaustein and Nelson, 198 1) driven by high [Na+],. Other investigators and I have argued that depletion of intracellular Ca*+ causes disruption of the AChR clusters of cultured rat myotubes (Bloch, 1983; Bursztajn et al., 1984) . If a rise in intracellular Ca2+ is an important factor in carbachol-induced cluster loss, then, to account for all my results, receptor clustering would have to show a "bellshaped" or biphasic dependence on intracellular Ca2+. This would be consistent with the data in Figure 5C (solid line). A disruptive effect on clusters of increased intracellular Ca2+ would also be consistent with observations (Bloch, unpublished observations) that the ionophore, A23 187 at concentrations that cause contraction and loss of some myotubes, causes cluster loss in most remaining cells. However, in two experiments using carbachol, I have failed to observe increased 45Ca2+ influx into myotubes (unpublished observations). It is therefore possible that CaZ+ influx does not increase during carbachol treatment.
It is difficult, nevertheless, to account for the effect of Ca*+ by postulating that it acts either extracellularly or at the level of the plasma membrane. Based on their observation that high extracellular Ca2+ induces cluster growth, Bursztajn et al. (1984) suggested that Ca2+ might promote interaction of the muscle membrane with "extracellular elements," thereby stabilizing AChR clusters. Several authors have also suggested that increased local concentrations of Ca2+ might promote AChR desensitization (Magazanik and Vyskocil, 1970; Manthey, 1966; Nastuk and Parsons, 1970) . The observation that lowering, rather than raising, extracellular Ca2+ protects against cluster loss is inconsistent with the possibility that changes in these interactions account for the loss of AChR clusters induced by carbachol.
Other investigators have suggested specific molecules that might mediate the affect of Ca*+ on the stability of AChR-rich membrane. Salpeter and her colleagues (Leonard and Salpeter, 1979; Salpeter et al., 1982b) have shown that increased postsynaptic Ca2+ concentrations can activate neutral proteases, and that this causes disruption ofpostsynaptic morphology. To learn if similar enzymes participate in cluster loss in rat myotubes treated with carbachol, I treated myotube cultures with specific protease inhibitors. Such treatments gave little protection of clusters (Table 4) . Ca2+-activated neutral proteases are therefore probably not involved. Peng (1984) has suggested that calmodulin might be involved in regulation of AChR clustering. This possibility is difficult to assess. All organic inhibitors of calmodulin, including fluphenazine (Landry et al., 198 1; Weiss et al., 1980) , exert their effects on calmodulin at micromolar concentrations. At these same concentrations, the phenothiazines promote AChR desensitization (Carp et al., 1983; Maleque et al., 1983) , a process that alone should protect against cluster loss caused by carbachol. In the same concentration range, these and other calmodulin inhibitors can also act as local anesthetics (e.g., Creese et al., 1978; Seeman, 1972) . It is therefore difficult to distinguish the effects of these drugs on calmodulin from their effects on AChR and on general membrane structure.
In summary, it is not yet clear how or where Ca2+ participates in the disruption of AChR clusters induced by carbachol, nor is the identity of the macromolecules that mediate the action of Caz+ apparent.
Local effects of carbachol Although carbachol may interact equally well with AChR anywhere in the muscle membrane, it may promote cluster loss by interacting with the receptors within clusters. About 10% of the total number of AChR in cultures of rat myotubes are in clusters, where they are present at densities 1 O-fold higher than receptors elsewhere on the cell surface (Axelrod et al., 1976; Land et al., 1977; Salpeter et al., 1982a) . When these clustered AChR bind carbachol, the local ionic changes that result may be greater than those occurring away from clusters. This may help to explain some of the differences between myotubes treated with carbachol and those treated with veratridine or gramicidin. The former change shape slightly (e.g., Fig. 1 ), but the latter tend to swell and contract. Both veratridine and gramicidin would probably promote Na+ flux more or less uniformly around the muscle membrane. They may cause relatively uniform increases in ionic concentration throughout the myoplasm and induce shape changes or contraction at the same drug concentrations that cause cluster loss. Because its effects would be enhanced in areas of high AChR density, carbachol might alter cluster stability before it grossly affected cell shape.
The potentially disruptive effect of carbachol on AChR clusters suggests that only low levels of neurotransmission may be tolerated at early stages of development of the neuromuscular junction. This is consistent with several observations. The initial formation of AChR aggregates at the developing postsynaptic membrane does not require functional neurotransmission Dennis et al., 198 1) . Electrical or synaptic activity more intense than that seen at developing synapses (Dennis et al., 198 1) seems to prevent or reverse the formation of postsynaptic receptor aggregates. For example, electrical stimulation suppresses receptor accumulation at newly forming ectopic synapses in denervated adult muscle (Lsmo and Slater, 1978) . Also, as with cultured myotubes, exposure of the intact, embryonic rat muscle to carbachol causes the disappearance of postsynaptic AChR aggregates (Bloch and Steinbach, 1981) . During development, as the frequency and intensity of transmission at the neuromuscular junction increase (see Diamond and Miledi, 1962; Kidokoro et al., 1980; Kullberg et al., 1977) , the postsynaptic receptor aggregates become more resistant to disruption by electrical stimulation or cholinergic agonists (Bloch and Steinbach, 198 1; Lomo and Slater, 1978) .
Conclusion
Increased influx of Na+, induced by carbachol or by other treatments, probably destabilizes AChR clusters. The mechanism of destabilization is not yet understood, but two possibilities are worth investigating further. (1) Carbachol could indwce the internalization and degradation (down-regulation) of AChR in primary rat myotubes, as has been reported for chick myotubes and a mouse muscle cell line by others (Gardner and Fambrough, 1979; Noble et al., 1978) . Work now in progress has shown that exposure of rat myotube cultures to carbachol reduces the overall number of lZSI-BT binding sites by about 30%, but neither the time course nor the pharmacology of this decrease correlates with that observed for the loss of AChR clusters (Bloch, unpublished observations) . The possibility remains that carbachol causes cluster loss by "down-regulating" the clustered AChRs, which represent only about 10% of the total lZSI-BT binding sites on the cell surface. (2) AChR may be stabilized in clusters by binding to intracellular cytoskeletal structures (see Steinbach and Bloch, in press , for a review). Increased Na+ influx could reduce this binding or alter the cytoskeletal organization in the vicinity of clusters. Recent progress in isolating AChR clusters from rat myotube cultures by mild detergent extraction (Bloch, 1984) should permit these and other possibilities to be investigated in the near future.
